I-MAB (IMAB)
1.78
-0.02
(-1.11%)
USD |
NASDAQ |
Apr 30, 14:08
I-MAB Total Liabilities (Quarterly): 146.81M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 126.23M |
| June 30, 2023 | 146.81M |
| June 30, 2023 | 146.81M |
| December 31, 2022 | 168.68M |
| June 30, 2022 | 145.56M |
| June 30, 2022 | 145.56M |
| December 31, 2021 | 163.42M |
| June 30, 2021 | 106.47M |
| June 30, 2021 | 106.47M |
| Date | Value |
|---|---|
| December 31, 2020 | 108.16M |
| September 30, 2020 | 81.51M |
| June 30, 2020 | 48.63M |
| June 30, 2020 | 48.63M |
| December 31, 2019 | 539.14M |
| September 30, 2019 | 77.15M |
| June 30, 2019 | 494.61M |
| June 30, 2019 | 494.61M |
| December 31, 2018 | 484.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
48.63M
Minimum
Jun 2020
539.14M
Maximum
Dec 2019
185.20M
Average
145.56M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Zai Lab Ltd | 240.18M |
| WuXi Biologics (Cayman) Inc | 1.772B |
| Wuxi AppTec Co Ltd | 2.561B |
| Gracell Biotechnologies Inc (DELISTED) | 36.85M |
| Sinovac Biotech Ltd | 1.488B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 484.12M |
| Shareholders Equity (Quarterly) | 337.31M |
| Debt to Equity Ratio | 0.0174 |
| Current Ratio | 5.674 |
| Net Debt Paydown Yield | -0.92% |